Scotia Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-100,000
Closed -$1.45M 751
2016
Q4
$1.45M Buy
100,000
+50,000
+100% +$917K 0.02% 354
2016
Q3
$1.23M Sell
50,000
-100,000
-67% -$2.59M 0.02% 382
2016
Q2
$3.02M Buy
+150,000
New +$4.25M 0.06% 209

Other funds holding BHC

Scotia Capital's BHC Position: Q2 2024 in Review

Scotia Capital sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 86,436 shares — an estimated $909K sold.

Scotia Capital first reported a position in BHC in Q2 2013 and held it in 33 quarters. The position peaked at $28.8M in Q1 2014. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

  • Scotia Capital reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
  • Scotia Capital sold 86,436 Bausch Health shares in Q2 2024, an estimated $909K.
  • Scotia Capital first reported a position in Bausch Health in Q2 2013 and held it in 33 quarters.
  • Scotia Capital's Bausch Health position peaked at $28.8M in Q1 2014.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on Scotia Capital's 13F filing for Q2 2024, filed 14 Aug 2024.